![Louis Plamondon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louis Plamondon worked as a Senior Director of Research & Development at Millennium Pharmaceuticals, Inc. He was also the Chief Scientific Officer & Senior Vice President at Tetraphase Pharmaceuticals, Inc. from 2006 to 2009.
Prior to that, he worked as a Principal at ProScript, Inc. and BASF Bioresearch Corp.
Dr. Plamondon received his undergraduate and doctorate degrees from the University of Montréal.
| Companies | Position | End |
|---|---|---|
BASF Bioresearch Corp. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Chief Tech/Sci/R&D Officer | - |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer treatments | Corporate Officer/Principal | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 11/09/2009 |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer treatments | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BASF Bioresearch Corp. |
Select your edition
All financial news and data tailored to specific country editions
